The utility of three different methods for measuring urinary 18-hydroxycortisol in the differential diagnosis of suspected primary hyperaldosteronism

European Journal of Endocrinology

Volumn 152, Issue 6, 2005, Pages 903-907

  Reynolds, R M ^c   Shakerdi, L A ^a   Sandhu, K ^b   Wallace, A M ^a   Wood, P J ^b   Walker, B R ^c  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

18 HYDROXYHYDROCORTISONE; GLUCOCORTICOID;

ADENOMA; ADRENAL HYPERPLASIA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ESSENTIAL HYPERTENSION; FLUOROMETRY; GAS CHROMATOGRAPHY; HUMAN; HYPERALDOSTERONISM; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METHODOLOGY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; URINALYSIS;

ADENOMA; ADRENAL HYPERPLASIA, CONGENITAL; DIAGNOSIS, DIFFERENTIAL; FLUOROMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPERTENSION; RADIOIMMUNOASSAY; RANDOM ALLOCATION; STATISTICS, NONPARAMETRIC;

EID: 21344460025     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01922     Document Type: Article

References (14)

1. Young WF. Minireview: Primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003 144 2208-2213.
2. Stewart PM. Mineralocorticoid hypertension. Lancet 1999 353 1341-1347.
3. Ulick S & Chu MD. Hypersecretion of a new corticosteroid. 18-hydroxycortisol, in two types of adrenocortical hypertension. Clinical and Experimental Hypertension 1982 4 1771-1777.
4. Chu MD & Ulick S. Isolation and identification of 18-hydroxycortisol from urine of patients with primary aldosteronism. Journal of Biological Chemistry 1982 257 2218-2224.
5. Corrie JET, Edwards CE & Budd PS. A radioimmunoassay for 18-hydroxycortisol in plasma and urine. Clinical Chemistry 1985 31 849-852.
6. Wenting GJ, Man in't Veld J, Derkx FH, Brummelen PV & Schalekamp MA. ACTH-dependent aldosterone excess due to adrenocortical adenoma: a variant of primary aldosteronism. Journal of Clinical Endocrinology and Metabolism 1978 46 326-335.
7. Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos GP & Allolio B. Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression. Clinical Endocrinology 1997 46 619-626.
8. Litton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S & Lalouel JM. A chimeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992 355 262-265.
9. Pascoe L, Curnow KM, Slutsker L, Connell JMC, Speiser PW, New MI & White PC. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. PNAS 1992 89 8327-8331.
10. Shackleton CHL. Mass spectrometry in the diagnosis of steroid-related disorders in hypertension research. Journal of Steroid Biochemistry and Molecular Biology 1983 45 1127-1140.
11. Gómez-Sánchez CE, Montgomery M, Ganguly A, Holland OB, Gómez-Sánchez EP, Grim CE & Weinberger MH. Elevated urmarv excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. Journal of Clinical Endocrinology and Metabolism 1984 59 1022-1024.
12. Gómez-Sánchez C, Gómez-Sánchez E & Holand B. Role of 18-hydroxylated cortisols in hypertension. Journal of Steroid Biochemistry 1987 27 971-975.
13. Mosso L, Gomez-Sanchez CE, Foecking MF & Fardella C. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension 2001 38 688-691.
14. Stowasser M, Bachmann AW, Tunny TJ & Gordon RD. Production of 18-oxo-cortisol in subtypes of primary aldosteronism. Clinical and Experimental Pharmacology & Physiology 1996 23 591-593.